Seven Fleet Capital Management LP — 13F Holdings & Portfolio
CIK 2092021 · latest 13F-HR filed 2026-08-17
Seven Fleet Capital Management LP manages $605.9M in 13F-reported U.S. long-equity assets across 114 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CGON (16.88%), TNGX (8.99%), TNGX (6.80%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 24 new positions and exited 43; 50 existing positions rose in reported value and 16 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-17
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- CG ONCOLOGY INC$128.9M +2513.8%
- TANGO THERAPEUTICS INC$85.2M +810.9%
- REVOLUTION MEDICINES INC$37.5M +476.9%
- PHARVARIS N V$21.9M +448.9%
- LIQUIDIA CORPORATION$13.4M +188.5%
Top Trims
- AGIOS PHARMACEUTICALS INC-$5.0M -70.2%
- VAXCYTE INC-$4.5M -71.8%
- COMPASS THERAPEUTICS INC-$2.2M -81.3%
- IDEAYA BIOSCIENCES INC-$1.5M -50.9%
- LIPOCINE INC NEW-$796.5K -79.8%
New Positions
- MIRUM PHARMACEUTICALS INC$12.9M
- VERADERMICS INC$9.8M
- EDITAS MEDICINE INC$4.3M
- SUTRO BIOPHARMA INC$3.8M
- ASCENDIS PHARMA A/S$3.2M
Exited Positions
- CG ONCOLOGY INC$97.4M
- TYRA BIOSCIENCES INC$7.5M
- TANGO THERAPEUTICS INC$6.3M
- AVALO THERAPEUTICS INC$5.4M
- MINERVA NEUROSCIENCES INC$5.4M
Seven Fleet Capital Management LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 156944100 | $102.3M | 16.88% | 1,439,393 | SH |
| 2 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $54.4M | 8.99% | 1,909,593 | SH |
| 3 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $41.2M | 6.80% | 1,318,551 | SH |
| 4 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $36.4M | 6.01% | 194,363 | SH |
| 5 | CG ONCOLOGY INC | CGON | 156944100 | $31.7M | 5.24% | 446,843 | SH |
| 6 | PHARVARIS N V | PHVS | N69605108 | $16.7M | 2.75% | 482,524 | SH |
| 7 | ABIVAX SA | ABVX | 00370M103 | $14.8M | 2.45% | 111,334 | SH |
| 8 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $14.7M | 2.42% | 289,136 | SH |
| 9 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $14.5M | 2.40% | 182,103 | SH |
| 10 | MIRUM PHARMACEUTICALS INC | MIRM | 604749101 | $12.9M | 2.13% | 110,393 | SH |
| 11 | PHARVARIS N V | PHVS | N69605108 | $10.1M | 1.67% | 291,977 | SH |
| 12 | CYTOKINETICS INC | CYTK | 23282W605 | $10.1M | 1.66% | 118,240 | SH |
| 13 | TAYSHA GENE THERAPIES INC | TSHA | 877619106 | $9.9M | 1.64% | 1,504,400 | SH |
| 14 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $8.9M | 1.47% | 47,666 | SH |
| 15 | VERADERMICS INC | MANE | 922967104 | $8.6M | 1.42% | 70,000 | SH |
| 16 | ARRIVENT BIOPHARMA INC | AVBP | 04272N102 | $8.6M | 1.41% | 246,606 | SH |
| 17 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $8.1M | 1.34% | 438,552 | SH |
| 18 | TARSUS PHARMACEUTICALS INC | TARS | 87650L103 | $7.9M | 1.31% | 117,067 | SH |
| 19 | XENCOR INC | XNCR | 98401F105 | $7.8M | 1.29% | 368,305 | SH |
| 20 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $7.8M | 1.29% | 220,126 | SH |
| 21 | CENTURY THERAPEUTICS INC | IPSC | 15673T100 | $7.2M | 1.19% | 2,947,826 | SH |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 05464T104 | $7.1M | 1.16% | 28,826 | SH |
| 23 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $7.0M | 1.15% | 148,647 | SH |
| 24 | ASSEMBLY BIOSCIENCES INC | ASMB | 045396207 | $6.2M | 1.03% | 226,415 | SH |
| 25 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $6.1M | 1.01% | 332,213 | SH |
| 26 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $5.9M | 0.98% | 74,500 | SH |
| 27 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $5.7M | 0.94% | 147,510 | SH |
| 28 | ASSEMBLY BIOSCIENCES INC | ASMB | 045396207 | $5.7M | 0.94% | 206,732 | SH |
| 29 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $5.6M | 0.92% | 45,400 | SH |
| 30 | EDITAS MEDICINE INC | EDIT | 28106W103 | $4.3M | 0.71% | 1,330,500 | SH |
| 31 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $4.3M | 0.70% | 43,672 | SH |
| 32 | MINERVA NEUROSCIENCES INC | NERV | 603380205 | $4.2M | 0.69% | 754,397 | SH |
| 33 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $4.0M | 0.66% | 154,430 | SH |
| 34 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $3.9M | 0.64% | 76,250 | SH |
| 35 | ERASCA INC | ERAS | 29479A108 | $3.9M | 0.64% | 210,346 | SH |
| 36 | SUTRO BIOPHARMA INC | STRO | 869367201 | $3.8M | 0.63% | 159,118 | SH |
| 37 | CENTURY THERAPEUTICS INC | IPSC | 15673T100 | $3.4M | 0.57% | 1,400,000 | SH |
| 38 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $3.4M | 0.56% | 130,000 | SH |
| 39 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $3.3M | 0.55% | 178,222 | SH |
| 40 | ASCENDIS PHARMA A/S | ASND | K08588103 | $3.2M | 0.52% | 11,869 | SH |
| 41 | SAGIMET BIOSCIENCES INC | SGMT | 786700104 | $3.1M | 0.51% | 403,545 | SH |
| 42 | ZAI LAB LTD | ZLAB | 98887Q104 | $2.9M | 0.48% | 136,016 | SH |
| 43 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $2.7M | 0.44% | 714,000 | SH |
| 44 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $2.7M | 0.44% | 4,973 | SH |
| 45 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $2.6M | 0.43% | 70,164 | SH |
| 46 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $2.5M | 0.42% | 7,540 | SH |
| 47 | RELMADA THERAPEUTICS INC | RLMD | 75955J402 | $2.4M | 0.40% | 348,265 | SH |
| 48 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 29842P105 | $2.2M | 0.37% | 334,785 | SH |
| 49 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $2.1M | 0.35% | 56,900 | SH |
| 50 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $2.1M | 0.34% | 33,300 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-17 | $605.9M | 114 | 0001013594-26-000921 |
| 2026-03-31 | 2026-06-04 | $318.3M | 115 | 0001013594-26-000652 |
| 2026-03-31 | 2026-05-15 | $315.1M | 114 | 0001013594-26-000616 |
| 2025-12-31 | 2026-04-02 | $147.8M | 87 | 0001013594-26-000420 |
| 2025-12-31 | 2026-02-26 | $131.5M | 87 | 0001013594-26-000305 |
MOUNTAIN VIEW, CA 94043